A detailed history of Strs Ohio transactions in Lyell Immunopharma, Inc. stock. As of the latest transaction made, Strs Ohio holds 5,100 shares of LYEL stock, worth $5,610. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,100
Previous 5,100 -0.0%
Holding current value
$5,610
Previous $7,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$1.71 - $3.07 $513 - $921
-300 Reduced 5.56%
5,100 $11,000
Q3 2021

Oct 22, 2021

BUY
$11.0 - $17.95 $59,400 - $96,930
5,400 New
5,400 $79,000

Others Institutions Holding LYEL

About Lyell Immunopharma, Inc.


  • Ticker LYEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 247,824,992
  • Market Cap $273M
  • Description
  • Lyell Immunopharma, Inc., a T cell reprogramming company, engages in developing T cell therapies for patients with solid tumors. The company develops therapies using technology platforms, such as Gen-R, an ex vivo genetic reprogramming technology to overcome T cell exhaustion; and Epi-R, an ex vivo epigenetic reprogramming technology to generate...
More about LYEL
Track This Portfolio

Track Strs Ohio Portfolio

Follow Strs Ohio and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.